POSSIBILITIES TO USE L-ORNITINE-L-ASPARTATE IN THERAPY OF NON-ALCOHOL FATTY LIVER DISEASE PATIENTS

Abstract

Today, NAFLD is one of the most common pathologies in the structure of liver diseases. Because the liver itself is involved in many pathological processes, its dysfunction contributes to the development of serious metabolic disorders, detoxification and antimicrobial defense of the body. One of the most frequent complications of liver disease is hepatic encephalopathy, which in most cases is latent.

Keywords

• liver
• nafld
• encephalopathy
• l-ornithine-l-aspartate